Contact
Please use this form to send email to PR contact of this press release:
MacroGenics Announces Submission of Margetuximab Biologics License Application to U.S. FDA
TO:
Please use this form to send email to PR contact of this press release:
MacroGenics Announces Submission of Margetuximab Biologics License Application to U.S. FDA
TO: